Reflections on Pills and Poverty

World Bank and International Monetary Fund. Global monitoring report 2007: millennium development goals. Washington, DC: IMF World Bank Publications; 2007: p. 3.

Commission on Intellectual Property Rights, Innovation and Public Health. Public health: innovation and intellectual property rights. Geneva: World Health Organization; 2006.

Shah A . Poverty facts and stats. In: Causes of poverty. Available: www.globalissues.org/TradeRelated/Facts.asp (accessed Oct. 17, 2007).

Govindaraj R Reich MR Cohen JC . World Bank Pharmaceuticals. HNP Discussion Paper. Washington, DC: World Bank; 2000.

Gwatkin DR Bhuiya A Victora CG . Making health systems more equitable. Lancet 2004;364(9441):1273–80.

Management Sciences for Health. Strategies for Enhancing Access to Medicines (SEAM). Key Findings from Ghana assessment. 2003. Available: www3.msh.org/seam/country_programs/3.1.3.htm (accessed Oct. 17, 2007).

Management Sciences for Health. Drug Management Program: defining and measuring access to essential drugs, vaccines, and health commodities. Report of the WHO-MSH consultative meeting, Ferney-Voltaire, France, 11–13 December 2000.

Reich M . The global drug gap. Science 2000;287(5460):1979–81.

Attridge CJ Preker AS . Improving access to medicines in developing countries. World Bank HNP Discussion Paper Series, March 2005, p. 11.

Médecins Sans Frontières (MSF). Fatal imbalance: the crisis in research and development for drugs for neglected diseases. Geneva: Campaign for Access to Essential Medicines/MSF; 2001. Available: www.accessmed-msf.org/prod/publications.asp?scntid=30112001115034&contenttype=PARA (accessed 27 May 2003).

Ewen M Dey D . Medicines: too costly and too scarce. Geneva: World Health Organization (WHO) and Health Action International (HAI); 2003. Available: www.haiweb.org/medicineprices/ (accessed July 23, 2007).

Cohen JC Cercone J Macaya R . Improving transparency in pharmaceutical systems: strengthening critical decision points against corruption. World Bank unpublished study. Prepared for Latin America and Caribbean Human Development Department; 2002.

McPake B Asiimwe D Mwesigye F Informal economic activities of public health workers in Uganda: implications for quality and accessibility of care. Soc Sci Med 1999;49(7):849–65.

Pecoud B Chirca P Trouiller P Finel J . Access to essential drugs in poor countries: a lost battle? JAMA 1999;281:361–7.

Chirac P Torreele E . Global framework on essential health R&D. Lancet 2006;367(9522):1560–1.

United Nations Economic and Social Council. Economic, social and cultural rights: the impact of the agreement on trade-related aspects of intellectual property rights on human rights. Report of the High Commissioner. E/CN.4/Sub.2/2001/13, June 27, 2001.

Cullet P . Patent and medicines: the relationship between TRIPS and the human right to health. International Affairs 2003;I:139.

Rodrik D . Has globalization gone too far? Washington, DC: Institute for International Economics; 1997: p. 82.

Stiglitz JE . Making globalization work. New York: W. W. Norton & Company; 2006.

Schott J , editor. The WTO after Seattle. Washington, DC: Institute for International Economics; 2000: p. 115.